VC  Civilization Ventures

http://www.civilizationventures.com/





     Office Locations:

500 Sansome St
San Francisco, CA 94111

 

Stages:

  • Early
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    Civilization Ventures is a venture capital firm focused on cutting-edge innovations in health tech and biology. The firm aims to be the lead investor in highly disruptive companies across digital health, synthetic biology, diagnostics, 3D (bio) printing, and AI / software-enabled health tech.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Ruxandra Tesloianu Analyst
    Shahram Seyedin-Noor Founder and General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/21/2024


      Insamo


      CA


      $12,000,000


      Seed


      10/24/2023


      DermBiont


      MA


      $35,200,000


      Series B


      04/27/2023


      Foresight Diagnostics


      CO


      $58,750,000


      Series B


     

    Portfolio companies include:

     

    Recent News: